Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 25,902 | 31,418 |
| Gross Profit | N/A | N/A | N/A | 25,902 | 31,418 |
| Operating Expenses | 38,602 | 14,095 | 11,869 | 69,376 | 83,249 |
| Operating Income | -38,602 | -14,095 | -11,869 | -43,474 | -51,831 |
| Interest Expense | 5,818 | 4,317 | -6,265 | 0 | 0 |
| Other Income | 2,705 | 978 | 24,295 | 10,197 | 6,093 |
| Pre-tax Income | -41,715 | -17,434 | 18,691 | -33,277 | -45,738 |
| Net Income Continuous | -41,715 | -17,434 | 18,691 | -33,277 | -45,738 |
| Net Income | $-41,715 | $-17,434 | $18,691 | $-33,277 | $-45,738 |
| EPS Basic Total Ops | -3.71 | -7.83 | 2.19 | -36.00 | -56.80 |
| EPS Basic Continuous Ops | -3.71 | -7.83 | 10.56 | -35.89 | -56.69 |
| EPS Diluted Total Ops | -3.71 | -7.83 | 2.17 | -36.00 | -56.80 |
| EPS Diluted Continuous Ops | -3.71 | -7.83 | 10.42 | -35.89 | -56.69 |
| EPS Diluted Before Non-Recurring Items | -3.71 | -7.83 | -9.60 | -36.00 | -56.80 |
| EBITDA(a) | $-38,602 | $-14,095 | $-11,869 | $-40,704 | $-49,372 |